HSKA stock forecast
Our latest prediction for Heska Corp.'s stock price was made on the Nov. 30, 2018 when the stock price was at 103.98$.
In the short term (2weeks), HSKA's stock price should outperform the market by 0.72%. During that period the price should oscillate between -4.66% and +4.97%.
In the medium term (3months), HSKA's stock price should outperform the market by 1.63%. During that period the price should oscillate between -10.12% and +14.47%.Get email alerts
About Heska Corp.
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.
At the moment the company generates 129M USD in revenues.
On its last earning announcement, the company reported a profit of 0.15$ per share.
The book value per share is 14.66$
Three months stock forecastNov. 30, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|